Phillip D. Fromm

1.4k total citations
33 papers, 976 citations indexed

About

Phillip D. Fromm is a scholar working on Immunology, Oncology and Hematology. According to data from OpenAlex, Phillip D. Fromm has authored 33 papers receiving a total of 976 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Immunology, 11 papers in Oncology and 7 papers in Hematology. Recurrent topics in Phillip D. Fromm's work include Immunotherapy and Immune Responses (20 papers), Immune Cell Function and Interaction (11 papers) and T-cell and B-cell Immunology (11 papers). Phillip D. Fromm is often cited by papers focused on Immunotherapy and Immune Responses (20 papers), Immune Cell Function and Interaction (11 papers) and T-cell and B-cell Immunology (11 papers). Phillip D. Fromm collaborates with scholars based in Australia, Germany and United States. Phillip D. Fromm's co-authors include Derek N.J. Hart, Heinrich Körner, P. Joy Ho, John Gibson, Christian Bryant, Ross Brown, Hayley Suen, James Favaloro, Douglas Joshua and Najah T. Nassif and has published in prestigious journals such as Blood, The Journal of Immunology and PLoS ONE.

In The Last Decade

Phillip D. Fromm

33 papers receiving 965 citations

Peers

Phillip D. Fromm

IMMUN

ONCOL

HEMAT

PHEOH

Maya C. André Germany

Matthew M. Seavey United States

Rami Yossef Israel

K L Simpson United Kingdom

Zhi Hong Lu United States

Ahuva Bar-Ilan Israel

Jill M. Wagner United States

Yasuo Kuwazuru Japan

Krzysztof Grzegorzewski United States

Cameron S. Brandt United States

Maya C. André Germany

Phillip D. Fromm

441 ×0.7

IMMUN

355 ×0.9

ONCOL

275 ×1.1

211 ×0.9

HEMAT

73 ×0.9

PHEOH

Citations per year, relative to Phillip D. Fromm Phillip D. Fromm (= 1×) peers Maya C. André

Countries citing papers authored by Phillip D. Fromm

Since Specialization

Citations

This map shows the geographic impact of Phillip D. Fromm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phillip D. Fromm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phillip D. Fromm more than expected).

Fields of papers citing papers by Phillip D. Fromm

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Phillip D. Fromm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phillip D. Fromm. The network helps show where Phillip D. Fromm may publish in the future.

Co-authorship network of co-authors of Phillip D. Fromm

This figure shows the co-authorship network connecting the top 25 collaborators of Phillip D. Fromm. A scholar is included among the top collaborators of Phillip D. Fromm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Phillip D. Fromm. Phillip D. Fromm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hey‐Cunningham, Alison J., et al.. (2021). Circulating and Endometrial Regulatory T Cell and Related Populations in Endometriosis and Infertility: Endometriosis Is Associated with Blunting of Endometrial Cyclical Effects and Reduced Proportions in Moderate-Severe Disease. Reproductive Sciences. 29(1). 229–242. 13 indexed citations

Abadir, Edward, Robin Gasiorowski, Kaitao Lai, et al.. (2019). CD300f epitopes are specific targets for acute myeloid leukemia with monocytic differentiation. Molecular Oncology. 13(10). 2107–2120. 7 indexed citations

Abadir, Edward, Robin Gasiorowski, Phillip D. Fromm, et al.. (2019). Examination of CD302 as a potential therapeutic target for acute myeloid leukemia. PLoS ONE. 14(5). e0216368–e0216368. 9 indexed citations

Kong, Benjamin Y., Holly A. Bolton, Julius W. Kim, et al.. (2019). On the Other Side: Manipulating the Immune Checkpoint Landscape of Dendritic Cells to Enhance Cancer Immunotherapy. Frontiers in Oncology. 9. 50–50. 12 indexed citations

Bryant, Christian, et al.. (2018). Dendritic cells as cancer therapeutics. Seminars in Cell and Developmental Biology. 86. 77–88. 50 indexed citations

Silveira, Pablo A., Phillip D. Fromm, Nirupama D. Verma, et al.. (2016). Characterization of the Expression and Function of the C-Type Lectin Receptor CD302 in Mice and Humans Reveals a Role in Dendritic Cell Migration. The Journal of Immunology. 197(3). 885–898. 20 indexed citations

Fromm, Phillip D., et al.. (2016). Fatal Leishmaniasis in the Absence of TNF Despite a Strong Th1 Response. Frontiers in Microbiology. 6. 1520–1520. 25 indexed citations

Fromm, Phillip D., et al.. (2016). A multi‐laboratory comparison of blood dendritic cell populations. Clinical & Translational Immunology. 5(4). e68–e68. 15 indexed citations

Anguille, Sébastien, Evelien Smits, Christian Bryant, et al.. (2015). Dendritic Cells as Pharmacological Tools for Cancer Immunotherapy. Pharmacological Reviews. 67(4). 731–753. 122 indexed citations

10.

Favaloro, James, Ross Brown, Shihong Yang, et al.. (2014). Myeloid derived suppressor cells are numerically, functionally and phenotypically different in patients with multiple myeloma. Leukemia & lymphoma. 55(12). 2893–2900. 91 indexed citations

11.

Berbic, Marina, Derek N.J. Hart, Phillip D. Fromm, et al.. (2014). Dendritic cells and impaired immune tolerance in infertility. Fertility and Sterility. 102(3). e137–e137. 1 indexed citations

12.

Favaloro, James, Ross Brown, Esther Aklilu, et al.. (2013). Myeloma skews regulatory T and pro-inflammatory T helper 17 cell balance in favor of a suppressive state. Leukemia & lymphoma. 55(5). 1090–1098. 64 indexed citations

13.

Wiede, Florian, Phillip D. Fromm, Iain Comerford, et al.. (2013). CCR6 is transiently upregulated on B cells after activation and modulates the germinal center reaction in the mouse. Immunology and Cell Biology. 91(5). 335–339. 25 indexed citations

14.

Bryant, Christian, Hayley Suen, Ross Brown, et al.. (2013). Long-term survival in multiple myeloma is associated with a distinct immunological profile, which includes proliferative cytotoxic T-cell clones and a favourable Treg/Th17 balance. Blood Cancer Journal. 3(9). e148–e148. 110 indexed citations

15.

Anguille, Sébastien, Eva Lion, Jurjen Tel, et al.. (2012). Interleukin-15-Induced CD56+ Myeloid Dendritic Cells Combine Potent Tumor Antigen Presentation with Direct Tumoricidal Potential. PLoS ONE. 7(12). e51851–e51851. 47 indexed citations

16.

Brown, Ross, James Favaloro, Shihong Yang, et al.. (2012). CD86+ or HLA-G+ can be transferred via trogocytosis from myeloma cells to T cells and are associated with poor prognosis. Blood. 120(10). 2055–2063. 84 indexed citations

17.

Fromm, Phillip D., Yanyan Mulyana, Ronald J. Clarke, et al.. (2011). Mechanism of Cytotoxicity and Cellular Uptake of Lipophilic Inert Dinuclear Polypyridylruthenium(II) Complexes. ChemMedChem. 6(5). 848–858. 66 indexed citations

18.

Kling, Jessica C., René Gollan, Phillip D. Fromm, & Heinrich Körner. (2011). Redundancy of interleukin-6 in the differentiation of T cell and monocyte subsets during cutaneous leishmaniasis. Experimental Parasitology. 129(3). 270–276. 5 indexed citations

19.

Fromm, Phillip D., David Gottlieb, Kenneth F. Bradstock, & Derek N.J. Hart. (2011). Cellular therapy to treat haematological and other malignancies: progress and pitfalls. Pathology. 43(6). 605–615. 1 indexed citations

20.

Körner, Heinrich, Brendan J. McMorran, Dirk Schlüter, & Phillip D. Fromm. (2010). The role of TNF in parasitic diseases: Still more questions than answers. International Journal for Parasitology. 40(8). 879–888. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact